title: [Status report on the chemotherapy of ovarian cancer at special cancer centers in Hungary (2002-2003)].
abstract: Data on the first-line treatment of ovarian cancer in special centers of Hungary 2002 and 2003 are presented, involving 283 and 416 patients, respectively. Patients' age, clinical stage and histological type of the tumor were highly similar to literature data, while grades were different. Surgical effectiveness in case of IIIc staged tumors with >1 cm residual mass was 37%. The ratio of interval laparotomy was about 15%. Overall response rates of the first-line treatment of ovarian cancer was 82%, while the rate of complete remissions was 60%. The authors provide detailed analysis of factors that can improve the chemotherapy of ovarian cancer in Hungary.
authors.affiliation: Országos Onkológiai Intézet, Budapest 1122, Hungary. pulay@oncol.hu
authors.forename: Tamás
authors.initials: T
authors.lastname: Pulay
authors.forename: Márta
authors.initials: M
authors.lastname: Baki
authors.forename: György
authors.initials: G
authors.lastname: Bodoky
authors.forename: Magdolna
authors.initials: M
authors.lastname: Dank
authors.forename: József
authors.initials: J
authors.lastname: Cseh
authors.forename: András
authors.initials: A
authors.lastname: Csejtei
authors.forename: Sándor
authors.initials: S
authors.lastname: Csömör
authors.forename: József
authors.initials: J
authors.lastname: Erfán
authors.forename: Olga
authors.initials: O
authors.lastname: Esik
authors.forename: Zsolt
authors.initials: Z
authors.lastname: Faluhelyi
authors.forename: József
authors.initials: J
authors.lastname: Izsó
authors.forename: Zoltán
authors.initials: Z
authors.lastname: Hernádi
authors.forename: Kinga
authors.initials: K
authors.lastname: Kammerer
authors.forename: Károly
authors.initials: K
authors.lastname: Krommer
authors.forename: Tamás
authors.initials: T
authors.lastname: Magyar
authors.forename: Arpád
authors.initials: A
authors.lastname: Mayer
authors.forename: Eva
authors.initials: E
authors.lastname: Megyery
authors.forename: Katalin
authors.initials: K
authors.lastname: Moskovits
authors.forename: Lajos
authors.initials: L
authors.lastname: Pécsi
authors.forename: Béla
authors.initials: B
authors.lastname: Pikó
authors.forename: Tamás
authors.initials: T
authors.lastname: Pintér
authors.forename: Agnes
authors.initials: A
authors.lastname: Ruzsa
authors.forename: András
authors.initials: A
authors.lastname: Szánthó
authors.forename: István
authors.initials: I
authors.lastname: Szántó
authors.forename: János
authors.initials: J
authors.lastname: Szántó
authors.forename: Miklós
authors.initials: M
authors.lastname: Szucs
authors.forename: Zsuzsanna
authors.initials: Z
authors.lastname: Tálos
authors.forename: László
authors.initials: L
authors.lastname: Thurzó
authors.forename: Miklós
authors.initials: M
authors.lastname: Kásler
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002173:Cancer Care Facilities / Q000706:statistics & numerical data; D000077143:Docetaxel; D004317:Doxorubicin / Q000008:administration & dosage; D005260:Female; D006801:Humans; D006814:Hungary; D008875:Middle Aged; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D010052:Ovariectomy; D017239:Paclitaxel / Q000008:administration & dosage; D012189:Retrospective Studies; D043823:Taxoids / Q000008:administration & dosage; D019772:Topotecan / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D019772:Topotecan; D004317:Doxorubicin; D017239:Paclitaxel